Using electroconvulsive treatment and lithium together to treat acute manic episodes is common, but the effects of combining these therapies vary according to the literature. Some studies have found severe adverse side effects, while others have found the combination of both medications safe and helpful. To investigate potential adverse side effects, this study reports on two cases where bipolar affective disorder patients developed delirium after receiving electroconvulsive therapy and lithium concurrently. The delirium was attributed only to the combined administration of these medicines after ruling out other potential causes. Additionally, alterations in blood-brain barrier permeability, such as those caused by electroconvulsive therapy and age, increased the likelihood of delirium. As a result, caution should be taken when using this combination of medicines, especially in those predisposed to delirium. This study established links between these medications and adverse effects, such as delirium. Further research is necessary to determine the efficacy and risks of combining these medications, establish causality, and develop prevention strategies.
Objective: We intended to explore the demographic and smoking patterns and the association of exhaled carbon monoxide (CO) with nicotine use disorder among the adult population of the Kathua region of the Union Territory of Jammu and Kashmir, India, who visited the tobacco cessation center (TCC). Methods: We evaluated a regional representative sample of 189 adult patients (176 males and 13 females) who visited the TCC. Results: The mean age ± standard deviation (SD) of patients who visited TCC was 52.87 ± 14.67 years, and the mean duration ± SD of smoking tobacco was 23.23 ± 10.92 years. The exhaled CO was significantly correlated with participants who smoke early in the morning ( r [95% confidence interval (CI)] = 0.511 [0.396–0.609], p < 0.001), those with the number of cigarettes/day ( r [95% CI] = 0.868 [0.827–0.899], p < 0.001), and those with Fagerstrom Test for Nicotine Dependence (FTND) score ( r [95% CI] = 0.814 [0.760–0.858], p < 0.001). But the significant association was only reported with early morning smoking (odds ratio [OR; 95% CI] = 0.144, [0.029–0.72], p < 0.05), the number of cigarettes/day (OR 95% CI = 2.097 [1.391–3.159], p < 0.001), and FTND score (OR [95% CI] = 3.420 [2.153–5.483], p < 0.001). Conclusion: There were demographic variances in patients who visited the TCC compared to those in the community. The association of exhaled CO with nicotine dependency was well-established, and exhaled CO could be used as a noninvasive marker.